Karlis Trusinskis, MD

Home »  Archive »  1st Cardionale 2010 »  Speakers »  Karlis Trusinskis, MD

Karlis Trusinskis, MD

Karlis Trusinskis, MD

Karlis Trusinskis, MD | LV
Assistant, Research Institute of Cardiology, University of Latvia

Birth of date: July 18, 1973

Address Staraja Rusas Street 5–7
Riga, LV-1048
Latvia

E-mai: cardio (at) in­box.lv

education and training
• MD, Latvian Academy of Medicine, Riga, Latvia 1991–1997
• Cardiologist, University of Latvia, 1997–2002

postgraduate studies
Echocardiography, Monash Medical Centre, Melburne, Australia, 2000
Interventional Cardiology, San Donato Hospital, Milan, Italy 2002
Intereventional Cardiology, Glenfield University Hospital, Leicester, UK, 2003
Interevntional Cardiology, Catharina Hospital, Eindhoven, Netherlands 2005
• PhD studies, University of Latvia 2007–present

professional experience
• Research Institute of Cardiology, University of Latvia: Assistant, 2000-present
• Pauls Stradins Clinical University Hospital, Latvian Centre of Cardiology, Riga, Latvia:
Resident, Cardiology 1997–2002
Cardiologist 2002–
Cardiology Early Rehabilitation 2004–2006
Coronary Care Unit 2006–2008
Interventional Cardiologist 2004–

languages Latvian, English, Russian

publications
Prognostic value of tryptophan load test followed by serum kynurenine determination. Its comparison with pyridoxal-5-phosphate, kynurenine, homocysteine and neopterin amounts. Rudzite V, Fuchs D, Kalnins U, Jurika E, Silava A, Erglis A, Trusinskis K, Jegere S.
Advances in experimental medicine and biology; 2003;527:307–15.

Immune activation and degradation of tryptophan in coronary heart disease.
Wirleitner B, Rudzite V, Neurauter G, Murr C, Kalnins U, Erglis A, Trusinskis K, Fuchs D European journal of clinical investigation; 2003 Jul;33(7­):550–4.
Homocysteine, pyridoxal-5-phosphate and neopterin in patients with coronary heart disease.
V. Rudzite, A. Silava, U. Kalnins, A. Erglis, K. Trusinskis, M. Jaeger, D. Fuchs.
Pteridines 2001; 12: 120–29.

Significance of the determination of serum neopterin and homocysteine concentrations as well as pyridoxal-5-phosphate deficiency in patients with coronary heart disease.
V. Rudzite, A. Silava, U. Kalnins, A. Erglis, K. Trusinskis, M. Jaeger, D. Fuchs.
Pteridines 2001; 12: 130–134.

Comparing the sensitivity pf pyridoxal-5-phospate, homocysteine and neopterin in coronary heart disease.
V. Rudzite, A. Jurika, U. Kalnins, A. Erglis, K. Trusinskis, S. Jegere, B. Frick, D. Fuchs.
Pteridines 2002; 13(3): 100–103.

Changes in lipid metabolism in patients with coronary heart disease.
V. Rudzite, E. Jurika, U. Kalnins, A. Erglis, K. Trusinskis, S. Jegere.
Proceedings of the Latvian Academy of Sciences, Section B 2002; 56(3): 109–113.

Homocysteine, B vitamins and immune activation in coronary heart disease.
B. Frick, V. Rudzite, K. Schröcksnadel, U. Kalnins, A. Erglis, K. Trusinskis, D. Fuchs.
Pteridines 2003; 14: 82–87.

Serum concentration of C-reactive protein, neopterin and phospholipids in patients with coronary artery disease.
V. Rudzite, E. Jurika, D. Fuchs, B. Wirteiter, U. Kalnins, A. Erglis, K. Trusinskis.
Pteridines 2003; 14: 56–57.

Usefulness of neopterin, C-reactive protein, homocysteine, pyridoxal-5-phosphate, and phospholipid determination in coronary artery disease.
V. Rudzite, E. Jurika, K. Schroecksnadel, U. Kalnins, A. Erglis, K. Trusinskis, D. Fuchs.
Pteridines 2005; 16(1): 15–21.

Inflammation, homocysteine, pyridoxal-5-phosphate, and lipids in patients with coronary artery disease before and six month after coronary angioplasty followed by stent implantation.
V. Rudzite, E. Jurika, D. Fuchs, U. Kalnins, A. Erglis, K. Trusinskis.
Pteridines 2005; 16(4): 170–175.

Importance of the acute coronary syndrome register for the improvement of cardiac care in Latvia.
A.Erglis, I. Zakke, A. Maca, A. Kalvelis, K. Trusinskis, S. Jegere, I. Narbute.
Seminars in Cardiology 2006; 12(1): 8–13.

Intravascular Ultrasound Data and Results of Serum Biochemical Indices at tha Time of Stenting and after Six months in Patients with Coronary Artery Disease.
V. Rudzite, E. Jurka, A. Erglis, K. Trusinskis, S. Jegere, D. Fuchs
Pteridines, Vol17, 2006, 95–96

Acute Coronary Syndrome: Guidelines of Latvian Society of Cardiology.
A. Erglis, A. Kalvelis, I. Zakke, S. Jegere, A. Maca, I. Narbute, K. Trusinskis
2006, Riga, 69p

presentations
Secondary risk factors in the progression of coronary artery disease.
V. Rudzite, E. Jurika, D. Fuchs, U. Kalnins, A. Erglis, K. Trusinskis.
Proceedings of the 5th International Congress on Coronary Artery Disease (Frontiers in Coronary Artery Disease), B.S.Lewis, D.A.Halon, M.Y. Flugelman, G.F.Gensini eds., Bologna (Italy), Monduzzi editore, 2003; 175–178.

Simultaneous study of intravascular ultrasound data and results of serum biochemical indices at the time of stenting and after 6 month in patients with coronary artery disease.
V. Rudzite, E. Jurika, A. Erglis, K. Trusinskis, S. Jegere, D. Fuchs
Abstr. 2nd Baltic Cardiology Congress 2006, 28–30 September, Riga, Latvia. Seminars in Cardiology, 2006; 12(4): 190.

Unrotected left main PCI registry. Experience of Latvian Centre of Cardiology.
Erglis A, Narbute I, Jegere S, Kumsars I, Dombrovskis A, Lismanis A, Trusinskis K, Mintale I, Zakke I, Strazdins U, Saltups A.
Abstr. 18th Transcatheter Cardiovascular Therapeutics Symposium 2006. October 22–27, 2006, Washington, USA. Am J Cardiol. 2006; 98(8), suppl S1: 163M

Trends ir the management of acute coronary syndromes in Latvia from 2001 to 2006.
Erglis A, Zakke I, Jegere S, Narbute I, Maca A, Trusinskis K
Abstr. ESC Congress 2007. September 1–5, 2007, Vienna, Austria. Eur Heart J 2007; 28(suppl 1): 656–657.

C-Reactive Protein, Neopterin and Homocystein in the progression of coronary heart diseases.
V.Rudzite, V.Jurika, D.Fuchs U.Kalnins, A.Erglis, K.Trusinskis
XIX Nordic Congress of Cardiology, Odence, Denmark, June 4–6, 2003. Abstract Book 72; P 74.

Indices of inflammation and other secondary risk factors in the progression of coronary artery disease
V.Rudzite, E.Jurika, D.Fuchs, U.Kalnins, A.Erglis, K.Trusinskis.
Atherosclerosis Supplements 2004; 5: 38–39.

Do we need debulking prior to LM stenting? The Latvian experience.
Erglis A, Kumsars I, Narbute I, Jegere S, Dombrovskis A, Lismanis A, Trusinskis K, Sondore D, Mintale I, Zakke.
22nd Annual International Interventional Cardiology Symposium 2007), 11.-16. marts, 2007, Snowmass (Colorado, USA)

Nordic Bifurcation Study.
Erglis A, Narbute I, Kumsars I, Jegere S, Sondore D, Trusinskis K.
Interevntional Cardiology Conference Top 10 in PCI 2007, Oct 5th, Madrid (Spain)

Virtual Histology in Carotids.
K. Trusinskis, K. Strenge, D. Sondore, I. Narbute, S. Jegere, M. Zabunova, Z. Stelbauma, A. Grave. A.Erglis.
XXV Interventional Cardiology Symposium., Snowmass (Colorado, USA) March, 2009

Comparison of quantitative angiographic and intravascular ultrasound parameters after left main stenting
S. Jegere, I. Narbute, I. Kumsars, K. Trusinskis, D. Sondore, A. Grave, A. Erglis
Cardiology, Int J of Cardiovasc Medicine, Surgery, Pathology and Pharmacology: Abstracts and Program, XXII Nordic- Baltic Congress of VCardiology, Reykjavik, Iceland, June 2009; P095,105.p,134p

Virtual histology in carotid arteries.
K. Trusinskis, K. Strenge, D. Sondore, I. Narbute, S. Jegere, M. Zabunova, Z. Stelbauma, A. Grave. A.Erglis.
Cardiology, Int J of Cardiovasc Medicine, Surgery, Pathology and Pharmacology: Abstracts and Program, XXII Nordic- Baltic Congress of VCardiology, Reykjavik, Iceland, June 2009; 08–6, 63.p,134p
Stent thrombosis: data from single high volume center PCI registry
K. Trusinskis, K. Strenge, L. Glazere, D. Sondore, I. Narbute, S. Jegere, M. Zabunova, Z. Stelbauma, A. Grave. A.Erglis.
Cardiology, Int J of Cardiovasc Medicine, Surgery, Pathology and Pharmacology: Abstracts and Program, XXII Nordic- Baltic Congress of VCardiology, Reykjavik, Iceland, June 2009; P038,81.p,134p

Simple vesrus complex strategy in bifurcation treatment
I. Kumsars, I. Narbute, D. Sondore, A. Dombrovskis, A. Lismanis, K. Trusinskis, S. Jegere, G. Kucika, A. Erglis
Cardiology, Int J of Cardiovasc Medicine, Surgery, Pathology and Pharmacology: Abstracts and Program, XXII Nordic- Baltic Congress of VCardiology, Reykjavik, Iceland, June 2009; P039,81.p,134p.

Erglis A, Jegere S, Trusinskis K, Kumsars I, Sondore D, Narbute I. Stent Endothelization after Paclitaxel Eluting Stent Implantation in Left Main: A 3 Years Intravascular Ultrasound and Optical Coherence Tomography Follow-up. Abstr. 21st Transcatheter Cardiovascular Therapeutics Symposium 2009. September 21–25, 2009, San Francisco, USA. Am J Cardiol. 2009; 104(6), suppl 6A: 13D.

Jensen LO, Jegere S, Kumsars I, Narbute I, Sondore D, Trusinskis K, Lassen JF, Thuesen L, Erglis A. Intravascular Ultrasound Assessment of Crush versus Culotte Coronary Bifurcation Stenting Technique. A substudy from the Nordic Stent Technique Study. Abstr. 21st Transcatheter Cardiovascular Therapeutics Symposium 2009. September 21–25, 2009, San Francisco, USA. Am J Cardiol. 2009; 104(6), suppl 6A: 39D-40D.

Tissue Characterization in Acute Coronary Syndrome with ST-elevations
Trusinskis K, Strenge K, Sondore D, Juhnevica D, Kumsars I, Narbute I, Jegere S, Grave A, Stelbauma Z, Erglis A. Correlation between Tissue Characterization and Biochemical Markers in Acute Coronary Syndrome Patients. XXVI Interventional Cardiology Symposium., Snowmass (Colorado, USA) March, 2010.